Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14391569 | 0.80 | NOTUM (0.35) | MAPT | |
| SCHEMBL8815627 | 0.79 | — | — | |
| SCHEMBL3944013 | 0.75 | — | — | |
| SCHEMBL7157486 | 0.75 | GSK3B (0.43) | — | |
| Bicarbonate SCHEMBL9560498 | 0.73 | MAPT (0.31) | MAPT | |
| Oxalic Acid SCHEMBL9221351 | 0.71 | ACE (0.31) | — | |
| SCHEMBL4407911 | 0.71 | — | — | |
| SCHEMBL9708934 | 0.69 | — | — | |
| SCHEMBL5919521 | 0.68 | TSHR (0.49) | — | |
| Succinic Acid SCHEMBL6865697 | 0.67 | LMNA (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040023048-A1 | Enhanced bonding layers on native oxide surfaces | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-02-05 | — | — | US | claimed |
| US-8993117-B2 | Devices with multiple surface functionality | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2015-03-31 | — | — | US | disclosed |
| US-20120121661-A1 | DEVICES WITH MULTIPLE SURFACE FUNCTIONALITY | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2012-05-17 | — | — | US | disclosed |
| US-20120114935-A1 | DEVICES WITH MULTIPLE SURFACE FUNCTIONALITY | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2012-05-10 | — | — | US | disclosed |
| US-7931943-B2 | Depositing a layer of an omega functionalized organophosphorous compound on an oxide substrate, heating, depositing another layer by heating and bonding through the omega functionalized group; implantable medical devices | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2011-04-26 | — | — | US | disclosed |
| US-7507483-B2 | Enhanced bonding layers on native oxide surfaces | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-03-24 | — | — | US | disclosed |
| US-20080166470-A1 | Enhanced Bonding Layers on Native Oxide Surfaces | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2008-07-10 | — | — | US | disclosed |
| US-20060194008-A1 | Devices with multiple surface functionality | PRINCETON UNIVERSITY (US) | 2006-08-31 | — | — | US | disclosed |
| US-20040023048-A1 | Enhanced bonding layers on native oxide surfaces | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120121661-A1 | DEVICES WITH MULTIPLE SURFACE FUNCTIONALITY | PHOSPHO1, CD44, SELP | MAPT 4354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.